Sweden: Camurus carries out directed share issue to raise SEK1.09bn
Swedish biopharmaceutical company, Camurus, carried out a directed share issue of 2 million share on January 18, at a subscription price of SEK545 per...
France: Carmat looks to manage short-term financing challenge
Carmat, designer and developer of the Aeson total artificial heart, has announced a conditional agreement in principle with the EIB on new loan repayment...
Germany: Schott Pharma prices IPO
Schott Pharma has priced its IPO at €27.00 per share. This corresponds to a placement volume of €935m (US$1.04bn) and a free float of...
Advertisement
